- Biotechnology and Nanomedicine
- Clinical Neuroscience
- Cognitive and Behavioural Neuroscience
- Computational and Systems Neuroscience
- Molecular and Cellular Neuroscience
- Neuroimaging and Methodological research
Seminar on European Brain Council: POSTPOSED
The seminar on the activity of the European Brain Council scheduled on April, 14th has been postposed. You may view the…
- Biotechnology and Nanomedicine
- Clinical Neuroscience
- Cognitive and Behavioural Neuroscience
- Computational and Systems Neuroscience
- Molecular and Cellular Neuroscience
- Neuroimaging and Methodological research
- Uncategorized
HERE WE ARE!! The 50 most influential Alzheimer’s Disease research papers of the last five years.
Our Annals of Neurology 2013 manuscript has been included between the 50 most influential Alzheimer’s Disease research papers of the last…
- Biotechnology and Nanomedicine
- Clinical Neuroscience
- Cognitive and Behavioural Neuroscience
- Computational and Systems Neuroscience
- Molecular and Cellular Neuroscience
- Neuroimaging and Methodological research
- Uncategorized
Immunotherapy Trials for Alzheimer’s Disease: Need for Prognostic Biomarkers?
I’m glad to share with you all this manuscript I Co-Authored with Bengt Winblad. At the 8th International Conference on…
- Biotechnology and Nanomedicine
- Clinical Neuroscience
- Cognitive and Behavioural Neuroscience
- Computational and Systems Neuroscience
- Molecular and Cellular Neuroscience
- Neuroimaging and Methodological research
Seminar on “European Brain Council: activities and opportunities”
On April 14th, 2016 at 10 a.m in the building U8 – room 1 at the University of Milano-Bicocca in Monza…
Clinical Neuroscience and Behaviour: Prof. Cavanna, March 16th 2016
Clinical Neuroscience and Behaviour Prof. Andrea Eugenio Cavanna, MD PhD FRCP Consultant in Behavioural Neurology, BSMHFT, Birmingham, UK Hon. Professor in…
cyTRON project in Google Summer of Code
BIMIB has entered as a “mentor group” in the latest Google Summer of Code under the auspices of the National Resource…
New NeuroMI paper on ALS: MEF2 pathways disruption
Amyotrophic lateral sclerosis (ALS) is a progressive neuro-muscular disease characterized by motor neuron loss. MEF2D and MEF2C are members of the…